Sham HD-tDCS
Sham HD-tDCS is a medical device with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Recovering Arm Function in Chronic Post-stroke Patients Using Combined HD-tDCS and Virtual Reality Therapy
Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation
HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19
Clinical Trials (11)
Recovering Arm Function in Chronic Post-stroke Patients Using Combined HD-tDCS and Virtual Reality Therapy
Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation
HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19
Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)
Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS
High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of Schizophrenia
Modulation of an Experimental Prolonged Pain Model Using High Definition Transcranial Direct Current Stimulation
Investigating the Neural Correlates in Memory Retrieval After HD-tDCS
Patient Centered-Rehabilitation ver111090.1
All 11 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 11